X4 Pharmaceuticals, Inc Cost of Revenue in USD from 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
X4 Pharmaceuticals, Inc quarterly/annual Cost of Revenue history and growth rate from 2022 to Q3 2025.
  • X4 Pharmaceuticals, Inc Cost of Revenue for the quarter ending September 30, 2025 was $351K, a 54.6% increase year-over-year.
  • X4 Pharmaceuticals, Inc Cost of Revenue for the twelve months ending September 30, 2025 was $5.7M.
  • X4 Pharmaceuticals, Inc annual Cost of Revenue for 2024 was $797K.
  • X4 Pharmaceuticals, Inc annual Cost of Revenue for 2023 was $0.000.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Cost of Revenue, Annual (USD)

X4 Pharmaceuticals, Inc Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $5.7M $351K +$124K +54.6% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $5.57M $326K +$58K +21.6% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-08
Q1 2025 $5.51M $4.72M +$4.72M Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-01
Q4 2024 $797K $302K Oct 1, 2024 Dec 31, 2024 10-K 2025-03-26
Q3 2024 $227K +$227K Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q2 2024 $268K +$268K Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-08
Q1 2024 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-01
Q3 2023 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08

X4 Pharmaceuticals, Inc Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $797K +$797K Jan 1, 2024 Dec 31, 2024 10-K 2025-03-26
2023 $0 $0 Jan 1, 2023 Dec 31, 2023 10-K 2025-03-26
2022 $0 Jan 1, 2022 Dec 31, 2022 10-K 2025-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.